Karen Wu of Lucerna, Inc. in the U.S. seeks to develop a portable fluorescence-based device for the rapid detection of procalcitonin (PCT), a biomarker of early sepsis. An inexpensive, simple to use and highly durable device can aid in the early detection of neonatal sepsis, a major cause of infant mortality in developing countries.
Grant ID
OPP1032194
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False